0

LATAM women hypoactive sexual desire disorder treatment market expected to reach $170 Million by 2027

 
2022
LATAM women hypoactive sexual desire disorder treatment market expected to reach $170 Million by 2027

Report Code : A07587

quote demand for hyposexual desire disorder treatments is on the rise, owing to surge in prevalence of lifestyle ailments such as stress and depression. Furthermore, surge in surgical procedures that lead to sexual dysfunction is another major factor that fuels the market growth. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, "LATAM women hypoactive sexual desire disorder treatment market by Treatment Type and Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2019–2027," the LATAM women hypoactive sexual desire disorder treatment market size accounted for $131 million in 2019, and is expected to reach $170 million by 2027, registering a CAGR of 3.8% from 2020 to 2027. 

Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder among women of all ages, however it is also one of the most challenging disorders to address. It is the most common type of sexual dysfunction that occurs in women. HSDD is mainly associated with hyper function inhibition and hypo functional excitation regulated by neuromodulators in the brain. In addition, several physical conditions are also related to HSDD, which include anxiety, depression, diabetes, urinary incontinence, and multiple sclerosis. Its treatment includes psychotherapy or pharmacotherapy. Psychotherapy utilizes cognitive behavioral therapy, which offers counseling sessions with a sex therapist, whereas pharmacotherapy comprises treatment with numerous drugs, namely buspirone, bremelanotide, bupropion, flibanserin, and others. 

The LATAM women hypoactive sexual desire disorder (HSDD) treatment market is expected to experience significant growth during the forecast period, owing to rise in prevalence of lifestyle ailments, such as stress, depression, anxiety, prolonged fatigue, and rise in use of medicines that induce a state of hypoactive sexual desire disorder. In addition, rise in number of surgical procedures that lead to sexual dysfunction are also expected to boost the growth of LATAM women hypoactive sexual desire disorder treatment market during the forecast period. However, lack in awareness related to hypoactive sexual desire disorder are anticipated to hamper the market growth during the forecast period. Presence of strong pipeline products which present in late phases of clinical trials are expected to get approved for commercialization in the coming years. Hence, the presence of pipeline drugs offers a lucrative opportunity for the LATAM women hypoactive sexual desire disorder treatment market.  

COVID-19 Impact Analysis on LATAM Hypoactive Sexual Desire Disorder (HSDD) Treatment Market

Lockdowns had an adverse impact on every type of business in Latin America. For instance, non-essential businesses such as retail business that operate with a physical location with access to public were closed. Furthermore, non-essential construction was also halted, recreational and entertainment businesses such as gyms, movie theaters, art centers, race tracks, salon, and public & private social clubs were also closed under the lock downs. However, essential businesses such as grocery stores, chemist stores, hospitals, veterinary hospitals remained functional during lockdowns. Furthermore, the impact of COVID-19 on LATAM women hypoactive sexual desire disorder treatment market was fairly negative, owing to fall in demand and supply of drugs used in treatment. Furthermore, other factors that were responsible for a negative impact on the market included limited availability of medical care, shortage of healthcare staff, and rise in burden of COVID-19 related hospitalization. However, various governments are working toward ensuring undisrupted supply of drugs, which is expected to lead to a stabilization in the market overtime.  

The LATAM women hypoactive sexual desire disorder (HSDD) treatment market is segmented on the basis of type, sales channel, and country. By type, the market is categorized into buspirone and bupropion. On the basis of sales channels, it is divided into hospitals, clinics and online retailers. Country wise, it is classified into Brazil, Argentina, Chile, Colombia, Ecuador, Peru, and Rest of the LATAM. 

By type, the LATAM hypoactive sexual desire disorder treatment market is segmented into buspirone and bupropion. The buspirone segment is expected to exhibit fastest growth rate during the forecast period, owing to the fact that it is FDA approved treatment aimed at HSDD in premenopausal women, which makes it a preferred brand over the off label treatments. Furthermore, this treatment type has lesser side effects as compared to other treatment options present in the market. 

Country wise, Argentina is expected to exhibit the fastest growth during the forecast period. This is attributed to factors such as rise in healthcare infrastructure, surge in healthcare expenditure, and rise in awareness related to hypoactive sexual desire disorder.

Key Findings Of The Study 

  • By treatment type, in terms of value, the bupropion segment dominated the market in 2019, and is anticipated to maintain its dominance throughout the forecast period
  • By sales channel, the clinics segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • By treatment type, the bupropion segment accounted for more than half the share of the market in 2019. 
  • By country, Argentina is anticipated to grow at the highest rate during the analysis period.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote LATAM Women Hypoactive Sexual Desire Disorder (HSDD) Treatment Market by Treatment Type (Buspirone and Bupropion), Sales Channel (Hospitals, Clinics, and Online Retailers): Regional Opportunity Analysis and Industry Forecast, 2020–2027 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Dec 2024

Gas Meter Market

Download Sample

Buy Full Version
"LATAM women hypoactive sexual desire disorder treatment market expected to reach $170 Million by 2027"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers